EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Diabetes mellitus: An updated overview and role of medicinal plants in modern treatment

Ashish Vishwakarma, Vasudev Biswas, Faizul Hasan, Asma Praveen, Divya Sharma

Innovative Medicines & Omics · 2025

DOI: 10.36922/imo.7520 ↗
AbstractBibliografische Angaben

Abstract

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by inadequate insulin production or peripheral insulin resistance, leading to persistent hyperglycemia. Prolonged hyperglycemia levels can cause severe complications, including nephropathy, neuropathy, retinopathy, and cardiovascular diseases. Diabetes is classified into four main types: Type 1 DM, type 2 DM, gestational DM, and maturity-onset diabetes of the young, each with distinct etiologies and clinical manifestations. Present therapeutic strategies encompass pharmacological interventions and lifestyle modifications; however, these approaches have limitations, such as adverse effects and reduced efficacy over time. Cutting-edge treatments, including stem cell therapy, gene therapy, nanotechnology, and medicinal plant-based therapies, offer promising avenues for improved diabetes management and potential cure. Several medicinal plants, including gudmar, bitter melon, and fenugreek, contain natural compounds that regulate blood glucose levels, boost insulin secretion, and mitigate oxidative stress, positioning them as valuable adjuncts in diabetes management. This review provides a comprehensive analysis of diabetes pathophysiology, classification, and present management strategies, highlighting the necessity for novel treatment approaches in response to the global diabetes epidemic.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →